What happened
Hanall Biopharma disclosed a plan to sell treasury shares worth US$128K, about 0.0% of its market value.
For context, this equals about 0.0% of the company's market value.
| Disposal amount | US$128K |
|---|---|
| vs. market value | 0.0% |
| Filed | 2026-03-09, Material event report (treasury share disposal) |
| Source | DART rcept 20260309001777 → open original filing |
Source: DART. Information only, not investment advice.